Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mattar

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2021
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic <i>NRG1</i> FusionsIgor Odintsov, Allan J W Lui, Whitney J Sisso, et al.
Journal of Ethnopharmacology|December 23, 2009
Evaluation of the subchronic toxicity of oral treatment with Chenopodium ambrosioides in miceWanderson S Pereira, Bruno P Ribeiro, Anildes I P Sousa, et al.
BMC Complementary and Alternative Medicine|November 8, 2011
Antimicrobial activity against oral pathogens and immunomodulatory effects and toxicity of geopropolis produced by the stingless bee Melipona fasciculata SmithSilvana A Liberio, Antônio Luís A Pereira, Richard P Dutra, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
<i>RRAS</i> and <i>RRAS2</i> mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
JCO Precision Oncology|August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic RelevanceKoichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell TumorTom Zhang, Christopher A Febres-Aldana, Zebing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2020
Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell TumorKoichi Ogura, Romel Somwar, Julija Hmeljak, et al.
Natural Product Research|April 19, 2011
Pharmacognostic and acute toxicological evaluation of Scaptotrigona aff. postica propolis extract in pre-clinical assaysM J A M Araújo, N S Mattar, A S Reis, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Conserved fiber topography of the anterior limb of the internal capsule in treatment-resistant psychiatric patientsReem El Jammal, Hideo Suzuki, Layth S Mattar, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2021
The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic <i>NRG1</i> FusionsIgor Odintsov, Allan J W Lui, Whitney J Sisso, et al.
Journal of Ethnopharmacology|December 23, 2009
Evaluation of the subchronic toxicity of oral treatment with Chenopodium ambrosioides in miceWanderson S Pereira, Bruno P Ribeiro, Anildes I P Sousa, et al.
BMC Complementary and Alternative Medicine|November 8, 2011
Antimicrobial activity against oral pathogens and immunomodulatory effects and toxicity of geopropolis produced by the stingless bee Melipona fasciculata SmithSilvana A Liberio, Antônio Luís A Pereira, Richard P Dutra, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
<i>RRAS</i> and <i>RRAS2</i> mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
JCO Precision Oncology|August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic RelevanceKoichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell TumorTom Zhang, Christopher A Febres-Aldana, Zebing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2020
Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell TumorKoichi Ogura, Romel Somwar, Julija Hmeljak, et al.
Natural Product Research|April 19, 2011
Pharmacognostic and acute toxicological evaluation of Scaptotrigona aff. postica propolis extract in pre-clinical assaysM J A M Araújo, N S Mattar, A S Reis, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Conserved fiber topography of the anterior limb of the internal capsule in treatment-resistant psychiatric patientsReem El Jammal, Hideo Suzuki, Layth S Mattar, et al.
Pageof 5